The NPs go to rapid responses here. If a situation progresses to a code, then you get the whole team - Anesthesia, ICU Charge Nurse, NP, respiratory.
Our NPs routinely visit every patient for whom there is a positive primary screen as defined by the SSC protocol. That is separate from the Rapid Response scenario. -----Original Message----- From: Sepsisgroups [mailto:[email protected]] On Behalf Of [email protected] Sent: Monday, March 09, 2015 2:08 PM To: [email protected] Subject: Sepsisgroups Digest, Vol 147, Issue 1 Send Sepsisgroups mailing list submissions to [email protected] To subscribe or unsubscribe via the World Wide Web, visit https://urldefense.proofpoint.com/v2/url?u=http-3A__lists.sepsisgroups.org_listinfo.cgi_sepsisgroups-2Dsepsisgroups.org&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=5oEaqk-jhQUpqeAcnLFhr2UgDYfA5C7yf8D7DPAUkFs&e= or, via email, send a message with subject or body 'help' to [email protected] You can reach the person managing the list at [email protected] When replying, please edit your Subject line so it is more specific than "Re: Contents of Sepsisgroups digest..." Today's Topics: 1. Re: SSC Webcast Series Continues (Frubulotta) 2. Procalcitonin (Jeanie Bollinger) ---------------------------------------------------------------------- Message: 1 Date: Fri, 6 Mar 2015 15:47:21 +0000 From: Frubulotta <[email protected]> To: Lori Harmon <[email protected]> Cc: "[email protected]" <[email protected]> Subject: Re: [Sepsis Groups] SSC Webcast Series Continues Message-ID: <[email protected]> Content-Type: text/plain; charset="utf-8" Dear all Writing a chapter on rapid response to in hospital emergencies I would be grateful if you could let me know about your sepsis response team How many people on that Who is the lead Do you have any other teams in your hospital such as end of life or trachy team? Thank you Francesca Sent from my iPhone Francesca Rubulotta [email protected] > On 20 Sep 2013, at 22:37, Lori Harmon <[email protected]> wrote: > > Colleagues, > > Registration is now open for the next grant funded webcast in the SSC > series, The SSC as a Model for Mentoring The webcast, funded by the Gordon > and Betty Moore Foundation is scheduled for Tuesday, October 15, 2013, 1:00 > pm ? 2:00 pm U.S. Central Time. > > Description > A mentoring relationship is formed between two individuals who are committed > to improving their professional environment and the advancement of the > prot?g??s career. The Physician Assistant Section of the Society of Critical > Medicine values the professional growth that a structured mentoring program > can provide. They have identified the Surviving Sepsis Campaign as a prime > model for mentoring opportunities that will provide better patient care while > affording PAs unique growth opportunities. Such a relationship can be applied > to all professionals in the sepsis care team. > > In this webcast the PA section will share examples of Surviving Sepsis > Campaign elements that are prime mentoring activities. Presentations from the > viewpoint of the mentee, mentor, and an objective educator will set the stage > for participants to implement a mentoring program in their discipline that > can provide significant professional growth for all involved while furthering > the reach of the Surviving Sepsis Campaign. Time will be allotted for > questions and answers from the participants following the presentations. > > Faculty > Ryan O?Gowan, MBA, PA-C, FCCM > Managing Partner > Arete Healthcare Consulting, LLC > East Longmeadow, MA > > Marie Mullen, MD > Clinical Associate Professor of Emergency Medicine University of > Massachusetts North Worchester, MA > > Emanuel P. Rivers, MD > Vice Chairman and Director of Research Department of Emergency > Services Henry Ford Hospital Detroit, MI > > Learning Objectives > 1. Describe the role of mentor and mentee in a healthcare setting 2. > Explain the benefits of serving as a mentor 3. Write goals for a > mentoring relationship that uses the Surviving Sepsis Campaign as a > basis > > Best regards, > Lori > > Lori A. Harmon, RRT, MBA > Director, Program Development > Society of Critical Care Medicine > 500 Midway Drive > Mount Prospect, IL 60056 > O +1-847-493-6403 > F +1-847-493-6428 > [email protected] > https://urldefense.proofpoint.com/v2/url?u=http-3A__www.sccm.org&d=AwI > CAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_e > habt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tv > I&s=lZL5GJxuhON1smfI5lwy1_zv0eGuTmBusCHEGcucIoY&e= > > _______________________________________________ > Sepsisgroups mailing list > [email protected] > https://urldefense.proofpoint.com/v2/url?u=http-3A__lists.sepsisgroups > .org_listinfo.cgi_sepsisgroups-2Dsepsisgroups.org&d=AwICAg&c=QmPtDiFix > EjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmy > DpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=5oEaqk-jhQU > pqeAcnLFhr2UgDYfA5C7yf8D7DPAUkFs&e= -------------- next part -------------- An HTML attachment was scrubbed... URL: <https://urldefense.proofpoint.com/v2/url?u=http-3A__lists.sepsisgroups.org_pipermail_sepsisgroups-2Dsepsisgroups.org_attachments_20150306_23c2a1a7_attachment.html&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=vLwuer-uqW2XCv0UsRfHvioRXh5zjxwGDEVhafPGUhQ&e= > ------------------------------ Message: 2 Date: Wed, 4 Mar 2015 17:21:30 +0000 From: Jeanie Bollinger <[email protected]> To: "[email protected]" <[email protected]> Subject: [Sepsis Groups] Procalcitonin Message-ID: <[email protected]> Content-Type: text/plain; charset="us-ascii" I am reaching out to anyone with scientific data of the use of procalcitonin as a screening tool. I am finding that the latest guidelines from the SCCM does not recommend the use of procalcitonin as a screening tool but as a biomarker to assist the clinician in the discontinuation of empiric antibiotic therapy in patients who appeared septic. Would like to hear comments from others. Thank-you. Jeanie Bollinger MSN,RN,ACCNS-AG, CCRN Sepsis Clinical Nurse Specialist Nursing Department of Excellence Mission Health Asheville, NC Phone: 828-213-5878 Beeper: 828-207-2363 -----Original Message----- From: Sepsisgroups [mailto:[email protected]] On Behalf Of [email protected] Sent: Monday, March 02, 2015 3:07 PM To: [email protected] Subject: Sepsisgroups Digest, Vol 146, Issue 1 Send Sepsisgroups mailing list submissions to [email protected] To subscribe or unsubscribe via the World Wide Web, visit https://urldefense.proofpoint.com/v2/url?u=http-3A__lists.sepsisgroups.org_listinfo.cgi_sepsisgroups-2Dsepsisgroups.org&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=5oEaqk-jhQUpqeAcnLFhr2UgDYfA5C7yf8D7DPAUkFs&e= or, via email, send a message with subject or body 'help' to [email protected] You can reach the person managing the list at [email protected] When replying, please edit your Subject line so it is more specific than "Re: Contents of Sepsisgroups digest..." Today's Topics: 1. Sepsis screening in a maternity population (Riley, Bonnie S.) 2. Re: Sepsis in obstetrical patients (Dr.Sunil T Pandya) ---------------------------------------------------------------------- Message: 1 Date: Fri, 27 Feb 2015 20:38:20 +0000 From: "Riley, Bonnie S." <[email protected]> To: "[email protected]" <[email protected]> Subject: [Sepsis Groups] Sepsis screening in a maternity population Message-ID: <[email protected]> Content-Type: text/plain; charset="utf-8" I am reaching out to anyone who is working on a sepsis protocol for a maternity population. We use the SSC bundles for all our patients except the women's health population. Bonnie Riley MSN, RNC, CPHQ Performance Improvement Coordinator Medical Staff Services M2843 Houston Methodist Sugar Land Hospital Office: 281-274-7869 Fax: 281-274-8028 Houston Methodist. Leading Medicine. Houston Methodist is ranked by U.S.News & World Report as one of America's "Best Hospitals" in 11 specialties and designated as a Magnet hospital for excellence in nursing. Houston Methodist has also been named to FORTUNE? Magazine's "100 Best Companies to Work For?" list for nine years in a row. Visit us at houstonmethodist.org. Follow us at https://urldefense.proofpoint.com/v2/url?u=http-3A__twitter.com_MethodistHosp&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=6Kukios_3byf_cRbV6t_4xFgSZIzgTB3N1YMQZpKm40&e= and https://urldefense.proofpoint.com/v2/url?u=http-3A__facebook.com_HoustonMethodist&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=k-UoYKwLQM9-jwvRtcVD5YipVApM5Hm0OVov2DVLwmA&e= . ***CONFIDENTIALITY NOTICE*** This e-mail is the property of Houston Methodist and/or its relevant affiliates and may contain restricted and privileged material for the sole use of the intended recipient(s). Any review, use, distribution or disclosure by others is strictly prohibited. If you are not the intended recipient (or authorized to receive for the recipient), please contact the sender and delete all copies of the message. Thank you. -------------- next part -------------- An HTML attachment was scrubbed... URL: <https://urldefense.proofpoint.com/v2/url?u=http-3A__lists.sepsisgroups.org_pipermail_sepsisgroups-2Dsepsisgroups.org_attachments_20150227_2630e79d_attachment.html&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=a-hLb-DSWXzStUFSxMs0T06jpvouYQpgPGOTuVz0tog&e= > ------------------------------ Message: 2 Date: Sat, 28 Feb 2015 02:43:36 +0530 From: "Dr.Sunil T Pandya" <[email protected]> To: "Riley, Bonnie S." <[email protected]> Cc: "[email protected]" <[email protected]> Subject: Re: [Sepsis Groups] Sepsis in obstetrical patients Message-ID: <CAJ5VsPR7JmV+pLsm_yvkka_F+MNU0gVp3e_=REoBQEDK=gx...@mail.gmail.com> Content-Type: text/plain; charset="utf-8" Yes, we do have implemented the same protocol if pregnant women...with early CVP, arterial and Ultrasound guided fluid resuscitation. Well, what we have additionally found and incorporated in our protocol are as follows: 1. Atonic PPH management under these settings...quite common (Uterotonics...oxytocin can exaggerate hypotension, B-Lynch procedure etc) 2. CUlture placental bed tissue 3. Send immediately neonatal cultures...even if the new born appears normal! 4. Anticipate and prevent hypotension if LSCS is done under regional anaesthesia....they have exaggerated hypotension...in fact, we have diagnosed occult sepsis in retrospect by this exaggerated hypotensive response work-up! 5. Early ScVO2 measurements and lactate clearance are good markers for improvements. Total leukocyte counts are invariably elevated and are unreliable marker during peripartum period. 6. Beware of occult sepsis creeping in parturients with HELLP, AFLP and Thrombotic micro-angiopaties! High vigil is warranted. Best wishes, Sunil *------------* *Dr.Sunil T Pandya* *Medical Director* *Director, Anaesthesia, Pain and Surgical Intensive Care,* *Century Hospital, Hyderabad, India (https://urldefense.proofpoint.com/v2/url?u=http-3A__www.centuryhospital.in&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=Tmts8gJlxp8tUqVoYPUU0dHNj3tjc1W3AAjuD8RNE4g&e= <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.centuryhospital.in&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=Tmts8gJlxp8tUqVoYPUU0dHNj3tjc1W3AAjuD8RNE4g&e= >)* *Organizing Secretary, 8th Annual Conference of AOA India and 1st World Obstetric Anaesthesia **Congress, Hyderabad, 2015.* *Hon. Secretary, Association of Obstetric Anaesthesiologists, India (https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aoaindia.com&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=wInxytNoJdgd1Nf3nJ7R0RbTABW63x4nAsG3pITLAzs&e= <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aoaindia.com&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=wInxytNoJdgd1Nf3nJ7R0RbTABW63x4nAsG3pITLAzs&e= >)* *Hon. Secretary, Society of Obstetric Medicine, India* *EC member, Obstetric Anaesthesia Society Asia Oceania (OASAO)* *EC member, Academy of Regional Anaesthesia, India (https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aoraindia.com&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0t vI&s=VNf9ZPO9HEzrfgpRkaNigdLlCAwD7wBT1C2ghEzCk-4&e= <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.aoraindia.com&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=VNf9ZPO9HEzrfgpRkaNigdLlCAwD7wBT1C2ghEzCk-4&e= >)* *Programme director, Post doctoral fellowship in Anaesthesia for High risk Obstetrics,* *Head, **Dept. of Anaesthesia, Obstetric Critical care and Pain medicine,* *Fernandez Hospital (Health care for Women and the Newborn), **www.fernandezhospital.com <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.fernandezhospital.com&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=SP61xdWMFUPq0nMmRNOha-dNh8_7v9HbLnAMlaN7IOs&e= >* *Director, Prerna Anaesthesia and Critical Care Services Pvt Ltd (https://urldefense.proofpoint.com/v2/url?u=http-3A__www.prernaanaesthesia.com&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=GGGM2kRFIPUk-JzFgq45ioIU6qV3vzMCWnugb7ePksw&e= <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.prernaanaesthesia.com&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=GGGM2kRFIPUk-JzFgq45ioIU6qV3vzMCWnugb7ePksw&e= >)* *Hyderabad, India.* On Mon, Feb 23, 2015 at 11:02 PM, Riley, Bonnie S. < [email protected]> wrote: > Hello, > > > > Is anyone here using any version of the Surviving Sepsis Campaign in > an obstetrical population? > > > > If so, would you share your experience? I work Risk Management. My > background is both ICU and L&D. I see a need for the protocol, and so > does one of the physicians. We are researching successful strategies > for implementation. > > > > Thanks > > > > Bonnie Riley MSN, RNC, CPHQ > > Performance Improvement Coordinator > > Medical Staff Services M2843 > > Houston Methodist Sugar Land Hospital > > Office: 281-274-7869 > > Fax: 281-274-8028 > > > > Houston Methodist. Leading Medicine. > > Houston Methodist is ranked by *U.S.News & World Report* as one of > America's "Best Hospitals" in 11 specialties and designated as a > Magnet hospital for excellence in nursing. Houston Methodist has also > been named to *FORTUNE? * Magazine's "100 Best Companies to Work For?" > list for nine years in a row. Visit us at houstonmethodist.org. Follow > us at > https://urldefense.proofpoint.com/v2/url?u=http-3A__twitter.com_MethodistHosp&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=6Kukios_3byf_cRbV6t_4xFgSZIzgTB3N1YMQZpKm40&e= > and > https://urldefense.proofpoint.com/v2/url?u=http-3A__facebook.com_HoustonMethodist&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=k-UoYKwLQM9-jwvRtcVD5YipVApM5Hm0OVov2DVLwmA&e= > . > > ***CONFIDENTIALITY NOTICE*** This e-mail is the property of Houston > Methodist and/or its relevant affiliates and may contain restricted > and privileged material for the sole use of the intended recipient(s). > Any review, use, distribution or disclosure by others is strictly prohibited. > If you are not the intended recipient (or authorized to receive for > the recipient), please contact the sender and delete all copies of the > message. > Thank you. > > _______________________________________________ > Sepsisgroups mailing list > [email protected] > https://urldefense.proofpoint.com/v2/url?u=http-3A__lists.sepsisgroups > .org_listinfo.cgi_sepsisgroups-2Dsepsisgroups.o&d=AwICAg&c=QmPtDiFixEj > kMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDp > IdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=KINhH9lLosS2z > Iniug4KWUHy45lcCFRZZUnXQs5rwGg&e= > rg > > -------------- next part -------------- An HTML attachment was scrubbed... URL: <https://urldefense.proofpoint.com/v2/url?u=http-3A__lists.sepsisgroups.org_pipermail_sepsisgroups-2Dsepsisgroups.org_attachments_20150228_ff0553ff_attachment-2D0001.htm&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=YKEa-GTNup6nj6fg3RoG4y5RoIr8omkgsfrjO6T89Qg&e= > ------------------------------ Subject: Digest Footer _______________________________________________ Sepsisgroups mailing list [email protected] https://urldefense.proofpoint.com/v2/url?u=http-3A__lists.sepsisgroups.org_listinfo.cgi_sepsisgroups-2Dsepsisgroups.org&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=5oEaqk-jhQUpqeAcnLFhr2UgDYfA5C7yf8D7DPAUkFs&e= ------------------------------ End of Sepsisgroups Digest, Vol 146, Issue 1 ******************************************** ---------------------------------------------------------------------------------------------------- This message and its attachments may contain confidential and/or legally-sensitive information that is intended for the sole use of the addressee(s). Any unauthorized review, use, disclosure, or distribution of the information contained in this message and its attachments is prohibited. If you have received this message or any of its attachments in error, please destroy all originals and copies of the same and notify the sender immediately. ------------------------------ Subject: Digest Footer _______________________________________________ Sepsisgroups mailing list [email protected] https://urldefense.proofpoint.com/v2/url?u=http-3A__lists.sepsisgroups.org_listinfo.cgi_sepsisgroups-2Dsepsisgroups.org&d=AwICAg&c=QmPtDiFixEjkMvDKaP3E2Vb9C2z4M0PdarxyAHQ2iDQ&r=V0ZAs3K1GwKIYFap_ehabt6M2I51mJZmyDpIdXIIwH4&m=0JNhNbqsLF2rb6oyJMG6EpOeae4DmpegRPrrAIy0tvI&s=5oEaqk-jhQUpqeAcnLFhr2UgDYfA5C7yf8D7DPAUkFs&e= ------------------------------ End of Sepsisgroups Digest, Vol 147, Issue 1 ******************************************** _______________________________________________ Sepsisgroups mailing list [email protected] http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
